Virios Therapeutics (VIRI) Tops Q3 EPS by 3c

Virios Therapeutics (NASDAQ: VIRI) reported Q3 EPS of ($0.06), $0.03 better than the analyst estimate of ($0.09).

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

You May Also Be Interested In

• 'Ocean of opportunity': Wolfe initiates SpaceX at Buy ahead of historic IPO
• RH (RH) Tops Q1 EPS by 12c
• United Community Banks sells equipment finance unit for $1.9 billion